Abstract
Mycosis fungoides is a T-cell lymphoma of low grade malignancy that most probably originates in the skin; it was described in France by Alibert as early as 1806. The skin changes are characterized by a sequence beginning with ecze-matous patches that develop into infiltrated plaques and terminate in ulcerating tumours; its natural course ranges from 10 to 15 years. Mycosis fungoides affects predominantly elderly people with a slight male preponderance. Although the term chosen by Alibert clearly is ethymologically and aetiologically a misnomer, it was rapidly accepted and is still used today.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aberer W, Schuler G, Stingl G, Hönigsmann H, Wolff K (1981) Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 76:202–210
Ablin RJ, Morris AJ (1973) Thymus-specific antigens on thymic derived lymphocytes. Transplantation 15:415
Ackerman AB, Miller RC, Shapiro L (1966) Pustular mycosis fungoides. Arch Dermatol 93:221–225
Ackerman AB, Breza TS, Capland L (1974) Spongiotic simulants of mycosis fungoides. Arch Dermatol 109:218–220
Alibert JLM (1806) Description des maladies de la peau observées à l’Hopital St. Louis. Barrois l’aine’ et Fils, Paris
Altmeyer P (1981) Disseminierte pagetoide Retikulose? Mycosis fungoides? Z Hautkr 56:63–74
Asbell SO, Gadol N, Saluk P, Vonderheid EC, Brady LW (1978) Antibody-dependent cellular cyto-toxicity in patients with mycosis fungoides and Sézary syndrome. Int J Radiat Oncol Biol Phys 4:609–613
Bast C de, Moriame N, Wanet J, Ledoux M, Achten G, Kenis Y (1971) Bleomycin in mycosis fungoides and reticulum cell lymphoma. Arch Derm 104:508–512
Bazin E (1870) Lecons sur le traitment de maladies chroniques en general affections de la peau en particulier par l’emploi compare des eaux minérales de l’hydrothérapie et des moyens pharmaceutiques. Adrein Delahaye, Paris, p 425
Berger CL, Morrison S, Chu AC, Patterson J, Estabrook A, Takezak S, Sharon J, Warburton D, Irigoyen O, Edelson RL (1982) Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. J Clin Invest 70:1205–1215
Bernardou A (1972) Bleomycin in the reticuloses. Br Med J 285–286
Bernstein ID, Tarn MR, Nowinski RC (1980) Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science 207:68–71
Besnier E, Hallopeau H (1892) On the erythrodermia of mycosis fungoides. J Cutan Genitourin Dis 10:453
Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S (1984) Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. J Exp Med 159:783–797
Bluefarb SM (1955) Is mycosis fungoides an entity? Arch Dermatol 71:293–302
Bodensteiner DC, Skikne B (1982) Central nervous system involvement in mycosis fungoides. Diagnosis, treatment and literature review. Cancer 50:1181–1184
Bonneau H, Cosarini J-P (1967) Etude ultrastructurale d’un cas de mycosis fungoides. Bull Soc Fr Dermatol Syphil 74:612–617
Braathen LR, Førre Ø, Natvig J (1979) An antihuman T-lymphocyte antiserum: in situ identification of T cells in the skin of delayed-type hypersensitivity reaction, chronic photosensitivity dermatitis and mycosis fungoides. Clin Immun Immunopath 13:211–219
Braun-Falco O, Burg G, Schmoeckel C (1981) Recent advances in cutaneous lymphoma. Clin Exp Dermatol 6:89–109
Breathnach SM, McKee PH, Smith NP (1982) Hypopigmented mycosis fungoides: report of five cases with ultrastructural observations. Brit J Dermatol 106:643–649
Brehm G (1974) Verhalten vom Immunglobulin E bei ausgewählten Dermatosen. Arch Derm Forsch 248:329–337
Broder S, Bunn PA (1980) Cutaneous T-cell lymphomas. Semin Oncol 7:310–331
Brownlee TR, Murad TM (1970) Ultrastructure of mycosis fungoides. Cancer 26:686–698
Bryant E, Ronau SG, Iossifides IA (1982) Plasma cell myeloma in a patient with a cutaneous T-cell lymphoma. Cancer 50:2122–2125
Büchner S, Rufli T (1979) Manifestation eines malignen Lymphoms von hohem Malignitätsgrad im Spätstadium der Mycosis fungodes. Enzymzytochemische und immunzytologische Untersuchungen. Dermatologica 159:125–131
Bunn PA, Lamberg SI (1979) Report of the committee von staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725–728
Bunn PA, Huberman MS, Whang-Peng J, Schlechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD (1980) Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Ann Int Med 93:223–230
Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF (1980) DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest 65:1440–1448
Burg G, Braun-Falco O (1975) T- and B-Lymphozyten in Hautveränderungen kutaner Lymphome. Dtsch med Wschr 100:2562–2564
Burg G, Rodt H, Grosse-Wilde H, Braun-Falco O (1978) Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary’s syndrome. J Invest Dermatol 70:257–259
Calabresi P, Parks RE (1980) Antiproliferative agents and drugs used for immunosuppression. In: The Pharmacological Basis of Therapeutics. Edited by Gilman AG, Goodmann LS, Gilman A. New York, Macmillan 1980, pp 1256–1313
Cameron OJ (1933) Mycosis fungoides in mother and in daughter. Arch Dermatol Syphilol 27:232–236
Camisa C, Goldstein A (1981) Mycosis fungoides. Small bowel involvement complicated by perforation and peritonitis. Arch Dermatol 117:234–237
Cassuto JP, Kövary PM, Campagni JP, Simoney J, Maiolini R, Schneider M (1981) Mycosis fungoides associated with mediterranean lymphoma. Arch Dermatol Res 270:17–23
Castellino RA, Hoppe RT, Blank N, Young ST, Fuks Z (1979) Experience with lymphography in patients with mycosis fungoides. Cancer Treat Rep 63:581–586
Caya JG, Choi H, Tieu TM, Wollenberg NJ, Almagro UA (1984) Hodgkin’s disease followed by mycosis fungoides in the same patient. Cancer 53:463–467
Chu AC, MacDonald DM (1979) Identification in situ of T lymphocytes in dermal and epidermal infiltrates of mycosis fungoides. Br J Dermatol 100:177–189
Chu AC, Morgan EW, MacDonald DM (1980) Ultrastructural identification of T lymphocytes in tissue sections of mycosis fungoides. J Invest Dermatol 74:17–20
Chu AC, Berger CL, Kung P, Edelson RL (1982a) In situ identification of Langerhans’ cells in the dermal infiltrate of cutaneous T-cell lymphoma. J Am Acad Dermatol 6:350–354
Chu AC, Berger CL, Lynfield Y, Esseessee I, Edelson RL (1982b) Pathogenesis of cutaneous T cell lymphoma. In: Lymphoproliferative disorders of the skin. Ed Goos M, Christophers E, pp 57–64, Springer Berlin-Heidelberg-New York
Chu AC, Patterson J, Berger C, Edelson R (1982c) T-cell subpopulations of cutaneous T-cell lymphoma (CTCL). J Invest Dermatol 78:334
Chu AC, Patterson J, Goldstein G, Berger C, Takezaki S, Edelson RL (1982d) Thymopoietin-like substance in human skin. J Invest Dermatol 78:330
Chu AC, Berger CL, Edelson RL, Spittle M, Russell C, Smith N (1983a) Circulating T cells in cutaneous T-cell lymphoma – a study using monoclonal antibodies against normal and malignant T cells. Br J Dermatol 108:219–246
Chu AC, Robinson D, Catovsky D, Smith N (1983b) The Sézary cell – a phenotypic study in different dermatoses. 10th SCUR Annual meeting and 4th International Dermatopathology Colloquium, Berlin, 15.–18.7.83. Booklet of Abstracts, pp 31–32
Civatte J, Kapetis E (1977) Problems in histological diagnosis of mycosis fungoides. Bull Cancer 64:187–190
Claudy A, Schmitt D, Alario A, Brochier J, Perrot H, Thivolet J (1977) Immunocytological characterization of the mycosis fungoides tumour cells. Bull Cancer 64:241–248
Claudy AL, Delomier Y, Hermier C (1982) Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359). Arch Dermatol Res 273:37–42
Claudy AL, Rouchouse B, Boucheron S, Le Petit JC (1983) Treatment of cutaneous T-cell lymphoma with etretinate. Br J Dermatol 109:49–59
Cohen SR, Stenn KS, Braverman IM, Beck GJ (1980) Mycosis fungoides: clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 46:2654–2666
Coleman CN, Williams CJ, Flint A (1977) Hématologic neoplasia in patients treated for Hodgkin’s disease. N Engl J Med 297:1249–1252
Cooperrider PA, Roenigk HH (1978) Selective immunological evaluation of mycosis fungoides. Arch Dermatol 114:207–212
Cyr DP, Geokas MC, Worsley GH (1966) Mycosis fungoides. Hématologic findings and terminal course. Arch Dermatol 94:558–572
Daul CB, De Shazo RD (1983) AIDS: an update and interpretation. Ann Allergy 51:351–361
David M, Shohat B, Hazar B, Feuerman EJ, Joshua H (1980) Identification of T- und B lymphocytes on skin sections from patients with lymphoproliferative disorders of the skin. J Invest Dermatol 75:491–494
David M, Shohat B, Trainin N, Feuerman E (1980) Cell-mediated immunity in patients with mycosis fungoides in clinical remission. Cancer 46:41–44
Davis BH, Simpkins H (1982) Mycosis fungoides and Sézary syndrome: malignant cells with T-cell enzymatic properties. Lab Invest 40:251
Dobozy A, Hunydi J, Husz S, Kenderessy AS, Simon N (1977) Autoimmune anti-T cell antibodies in the sera of patients with mycosis fungoides. Brit J Dermatol 97:543–546
Edelson RL (1979) Cutaneous T cell lymphoma. In: Moschella S (ed) Dermatology update, pp 195–207. Elsevier Press New York
Edelson RL (1980) Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol 2:89–106
Edelson RL, Kirkpatrick CH, Shevach EM, Schein PS, Smith RW, Green I, Lutzner M (1974) Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Ann Int Med 80:685–692
Edelson RL, Berger CL, Raafat J, Warburton D (1979) Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. J Invest Dermatol 73:548–550
Epstein EH, Levin DL, Croft JD Jr, Lutzner MA (1972) Mycosis fungoides: survival, prognostic features, response to therapy and autopsy findings. Medicine 15:61–72
Erkman-Balis B, Rappaport H (1974) Cytogenetic studies in mycosis fungoides. Cancer 34:626–633
Farber EM, Zackheim HS, McClintock RP, Cox AJ (1968) Treatment of mycosis fungoides with various strengths of fluocinolone acetonide cream. Arch Dermatol 97:165–168
Fischer ER, Branimir LH, Wechsler HL (1972) Ultrastructural features of mycosis fungoides. Amer J Clin Path 58:99–110
Fischer T, Skogh M (1979) Treatment of parapsoriasis en plaques, mycosis fungoides, and Sézary’s syndrom with trioxalen baths followed by ultraviolet light. Acta Dermatovenerol 59:171–173
Fischer T, van Vloten WA, Volden G (1978) Internal dissemination of mycosis fungoides despite successful local therapy. Acta Dermatovener 58:88–89
Fischmann AB, Bunn PA Jr, Guccion JG, Matthews MJ, Minna JD (1979) Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndrome. Cancer Treat Rep 63:591–596
Flaxman BA, Zelazny G, van Scott EJ (1971) Nonspecificity of characteristic cells in mycosis fungoides. Arch Dermatol 104:141–147
Flaxman BA, Sosis AC, van Scott EJ (1973) Changes in melanosome distribution in caucasoid skin following topical application of nitrogen mustard. J Invest Dermatol 60:321–326
Focan C, Cryns-Lenain E, Bouhy F, Lapière C (1982) Clinical and histological staging as prognostic determinants in advanced cutaneous T cell lymphomas treated by sequential polychemotherapy with bleomycin, vinblastine and prednisone. Dermatologica 165:141–144
Fuks ZY, Bagshaw MA, Farber EM (1973) Prognostic signs and the management of the mycosis fungoides. Cancer 32:1385–1395
Fuks ZY, Castellino RA, Carmel JA, Farber EM, Bagshaw MA (1974) Lymphography in mycosis fungoides. Cancer 34:106–112
Fukuhara S, Rowley JD, Variakojis D (1978) Banding studies of chromosomes in a patient with mycosis fungoides. Cancer 42:2262–2268
Gahlen-Schulte S, Sterry W, Runne U (1982) Generalisierter Herpes simplex bei Mycosis fungoides (Ekzema herpeticum seu herpeticatum, Kaposi’s varizelliforme Eruption). Z Hautkr 57:1757–1765
Gauge RW, Jones EW (1978) Kaposi’s sarcoma and immunosuppressive therapy: an appraisal. Clin exp Dermatol 3:135–146
Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20
Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H (in press a) Proliferation rate in malignant non Hodgkin’s lymphomas as determined in situ with the monoclonal antibody Ki 67. Haematol Oncol
Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H (in press b) Cell cycle analysis of a cell proliferation associated nuclear antigen defined by the monoclonal antibody Ki 67. J Immunol
Gilchrest BA, Parrish JA, Tauenbaum L, Haynes HA, Fitzpatrick TB (1976) Oral methoxalen photo-chemotherapy of mycosis fungoides. Cancer 38:683–689
Glück S, Merck H, Sterry W, Goerz G, Schneider W (1983) Erhöhte Adenosin-Desaminase-Aktivität bei Patienten mit Mycosis fungoides. Hautarzt 34(Suppl. VI):337–338
Goldgeier MH, Cohen SR, Braverman IM, Stenn KS (1981) An unusual and fatal case of disseminated cutaneous herpes simplex. J Am Acad Dermatol 4:176–180
Goos M (1976) T-cell specific microenvironment in mycosis fungoides. Arch Dermatol Res 255:215–218
Green SB, Byar DP, Lamberg SI (1981) Prognostic variables in mycosis fungoides. Cancer 47:2671–2677
Greene MH, Dalager NA, Lamberg SI, Argyropoulos CE, Fraumeni JF Jr (1979) Mycosis fungoides: epidemiologic observations. Cancer Treat Rep 63:597–606
Griem ML, Moran EM, Ferguson DS, Mettler FA, Griem SF (1975) Staging procedures in mycosis fungoides. Br J Cancer (Suppl.) 31:362–367
Grossi CE, Webb SR, Zicca A, Lydyard PM, Moretta L, Mingardi MC, Cooper MD (1978) Morphological and histochemical analysis of two human T-cell subpopulations bearing receptors for IgM and IgG. J exp Med 147:1405–1417
Groth O, Molin L, Thomsen K (1979) Tumor stage of mycosis fungoides treated with bleomycin and methotrexate : report from the Scandinavian mycosis fungoides study group. Acta Dermato-vener 59:59–63
Hagedorn M, Kiefer G (1977) DNA content of mycosis fungoides cells. Arch Derm Res 258:127–134
Hamminga L, Hermans J, Noordijk EM, Meijer CJLM, Scheffer E, van Vloten WA (1982a) Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients. Br J Dermatol 107:145–156
Hamminga L, Leigh PC, Blussé van oud Alblas A, van Vloten WA, van Furth R (1982b) Functions of peripheral-blood monocytes and granulocytes in cutaneous T-cell lymphoma. Br J Dermatol 107:157–164
Hamminga B, Noordijk EM, van Vloten WA (1982c) Treatment of mycosis fungoides. Total-skin electron-beam irradiation vs topical mechlorethamine therapy. Arch Dermatol 118:150–153
Haserick JR, Richardson JR, Grant DJ (1959) Remission of lesions in mycosis fungoides following topical application of nitrogen mustard. Cleve Clin R 26:144–147
Haynes BF, Hensley LL, Jegasothy BV (1982a) Phenotypic characterization of skin infiltrating T-cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. Blood 60:463–473
Haynes BF, Hensley LL, Jegasothy BV (1982b) Differentiation of human T-lymphocytes : II Phenotypic differences in skin and blood malignant T-cells in cutaneous lymphoma. J Invest Dermatol 78:323–326
Heid E, Desvaux J, Brändie I, Grosshans E (1976) Der Verlauf der Parapsoriasis en plaques (Brocq’sche Krankheit). Z Hautkr 52:658–662
Herbst M, Müller R (1984) Ganz-Haut-Elektronentherapie der Mycosis fungoides und des Sézary-Syndroms. Hautarzt 35:16–21
Hjortshoj A, Schmidt H (1977) Photochemotherapy of mycosis fungoides. Danish Med Bull 24:40–42
Hodge L, Vella Briffa D, Warin AP, Gange RW, Bleeken S (1977) Photochemotherapy in mycosis fungoides. Br Med J 2:1257–1259
Hofmann C, Burg G, Plewig G, Braun-Falco O (1977) Photochemotherapie kutaner Lymphome. Orale und lokale 8-MOP-UVA-Therapie. Dtsch Med Wschr 102:675–679
Holden CA, Morgan EW, MacDonald DM (1982a) The cell population in the cutaneous infiltrate of mycosis fungoides: in situ studies using monoclonal antisera. Br J Dermatol 106:385–392
Holden CA, Staughton RCD, Campbell MA, MacDonald DM (1982b) Differential loss of T-lympho-cyte markers in advanced cutaneous T-cell lymphoma. J Amer Acad Dermatol 6:507–513
Hönigsmann H, Konrad K, Gschnait F, Wolff K (1976) Photochemotherapy of mycosis fungoides VIIth International Congress of Photobiology, Rome, Italy, 29. Aug.–3. Sept. 1976, Book of Abstracts, p 222
Hubermann MS, Bunn PA Jr, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD (1980) Hepatic involvement in the cutaneous T-cell lymphomas. Cancer 45:1683–1688
Hundeiker M, Berger H, Petres J (1968) Mycosis fungoides nach Thorotrastanwendung mit Entwicklung zur Retikulumzellsarkomatose. Arch klin exp Forsch 232:56–65
Hunziker T, Zala A, Krebs A (1983) Retinoid-orale Photochemotherapie (RePUVA) als Kombinationsbehandlung bei Mycosis fungoides. Dermatologica 166:165–168
Ippolito F, Giacalone B (1982) Sur un cas de mycosis fungoide avec manifestations tumorales traité avec Ro 10-9359 (Tigason). Ann Dermatol Venerol 109:65–72
Kerl H (1981) Das Sézary Syndrom. Zbl Haut Geschlkr 144:359–380
Kerl H, Hödl S, Smolle J, Konrad K (1984) Klassifikation und Prognose kutaner T-Zell-Lymphome. Z Hautkr (in press)
Klein D (1976) Staging procedures in mycosis fungoides. Proc Am Soc Clin Oncol 17:277
Knoth W (1976) Reticulosen. Hautarzt Suppl 1:295
Kragballe K, Herlin T, Ellegaard J (1983) Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides. Arch Dermatol 119:203–206
Kresbach H (1981) Kutane maligne Lymphome. Ältere Vorstellungen und neuere Konzepte. Münch med Wschr 35:1291–1296
Kubba RK, Bailin PL, Roenigk HH (1979) Immunological evaluation in mycosis fungoides: Before and after PUVA therapy. Arch Dermatol 116:178–181
Kubec K, Krtkova J (1971) Clinical experiences with cyclophosphamide in the treatment of two cases of mycosis fungoides. Cesk Dermatol 46:166–169
Kufe D, Major P, Agarwal R, Reinherz E, Frei E (1980) Phase I-phase II trial of deoxycoformycin (DCF) in T cell malignancies. Proc Am Assoc Cancer Res 21:328
Kummermehr J, Burg G (1982) Autoradiographic pattern of cell proliferation in cutaneous malignant lymphoma. In: Lymphoproliferative diseases of the skin. Eds. Goos M, Christophers E, pp 71–78 Springer Berlin-Heidelberg-New York
Lamberg SI, Diamond EL, Lorincz AL, Caro WA, Rappaport H, Variakojis D, Block JB, Fuks ZY, van Scott EJ (1975) Mycosis fungoides cooperative study. Arch Dermatol 111:457–459
Lamberg SI, Green SB, Byar DP, Block JB, Clendenning WE, Epstein EN, Fuks ZY, Golitz LE, Lorincz AL, Michel B (1979) Status report of 376 mycosis fungoides patients at 4 years — Mycosis fungoides cooperative group. Cancer Treat Rep 63:701–707
Lange Wantzin G, Larsen JK, Christensen IJ, Bruun Rasmussen B, Thomsen K (1983) Aneuploidy in cutaneous T-cell lymphoma. Acta Derm Venerol 63:283–289
Lawrence H (1969) Transfer factor. Advance Immunol 11:195–201
Leavell UW, DeSimone P (1976) Combined chemotherapy (COP) in treatment of mycosis fungoides: report of four cases. South Med J 69:915–917
Lee LA, Fritz KA, Golitz L, Weston WL (1982) Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard. J Am Acad Dermatol 7:592–598
Lee LA, Ryan SR, Huff JG, Schocket AL (1982) Lymphocytotoxic antibodies in mycosis fungoides are predominantly antisuppressor cell. J Invest Dermatol 78:337
Lefeber WR, Robinson JK, Clendenning WE, Dunn JL, Colton T (1981) Attempts to enhance light microscopic diagnosis of cutaneous T cell lymphoma (mycosis fungoides). Arch Dermatol 117:408–411
Lennert K (1978) Malignant lymphomas other than Hodgkin’s disease. Springer Verlag Berlin-Heidelberg-New York, pp 165–185
Lever WH, Schaumburg-Lever G (1983) Histopathology of the skin. 6th edition. J.P. Lippincott Co, Philadelphia
Levi JA, Wiernik PH (1975) Management of mycosis fungoides: Current status and future prospects. Medicine 54:73–88
Lipa M, Kunynetz R, Pawlowski D, Kerbel G, Haberman H (1982) The occurence of mycosis fungoides in two patients with preexisting Hodgkin’s disease. Arch Dermatol 118:563–567
Lischka G, Bohnert E, Bachtold G, Jung EG (1977) Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes. J Invest Dermatol 68:245
Lowe NJ, Cripps DJ, Dufton PA, Vickers FH (1979) Photochemotherapy for mycosis fungoides. A clinical and histological study. Arch Dermatol 115:50–53
Luger TA, Stadler BM, Katz SI, Oppenheim JJ (1981) Epidermal cell (keratinocyte)-derived thymo-cyte-activating factor (ETAF). J Immunol 127:1493–1502
Lutzner MA, Hobbs JW, Horwvath P (1971) Ultrastructure of abnormal cells in Sézary syndrome, mycosis fungoides, and parapsoriasis en plaques. Arch Dermatol 103:375–386
Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A (1975) Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides and related disorders. Ann Int Med 83:534–552
MacKie RM (1981) Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells. Lancet 2:283–285
MacKie RM, Turbitt ML (1982) The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides. Br J Dermatol 106:379–384
MacKie R, Dick HM, De Sousa MB (1976a) HLA and mycosis fungoides. Lancet 1 (7970), 1179
MacKie R, Sless FR, Cochran R, De Sousa M (1976b) Lymphocyte abnormalities in mycosis fun-goides. Br J Dermatol 94:173–178
Mahrle G, Thiele B, Ippen H (1983) Chemotherapie kutaner T-Zell-Lymphome mit Arotinoid. Dtsch med Wschr 108:1753–1757
Marmelzat WL (1963) Mycosis fungoides: local injections of triamcinolone. Calif Med 98:139–141
McMillan EM, Beeman K, Wasik R, Everett MA (1982a) Demonstration of OKT6-reactive cells in mycosis fungoides. J Am Acad Dermatol 6:880–887
McMillan EM, Wasik R, Beeman K, Everett MA (1982b) In situ immunologic phenotyping of mycosis fungoides. J Am Acad Dermatol 6:888–892
McMillan EM, Wasik R, Jackson I, Peters S, Everett MA (1982c) OKT6-reactive cells in mycosis fungoides. J Cut Pathol 9:55–60
McNutt NS, Crain WR (1981) Quantitative electron microscopic comparison of lymphocyte nuclear contours im mycosis fungoides and in benign infiltrates in skin. Cancer 47:698–709
Meijer CJ, van Leeuwen AW, van der Loo EM, van der Putte LB, van Vloten WA (1977) Cerebriform (Sézary-like) mononuclear cells in healthy individuals: a morphologically distinct population of T cells. Relationship with mycosis fungoides and Sézary’s syndrome. Virch Arch Cell Pathol 25:95–104
Meijer CJ, van der Loo E, van Vloten WA, Cornelisse J (1978) Early diagnosis of mycosis fungoides and Sézary’s syndrome by computer assisted morphometric analysis of lymphoid cells. J Invest Dermatol 70:234
Meijer CJ, van der Loo EM, van Vloten WA, van der Velde EA, Scheffer E, Cornelisse CJ (1980) Early diagnosis of mycosis fungoides and Sézary’s syndrome by morphometric analysis of lymphoid cells in the skin. Cancer 45:2864–2871
Miller RA, Levy R (1981) Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet 1:226–230
Molin L, Skogh M, Volden G (1978) Successful PUVA-treatment in the tumour stage of mycosis fungoides associated with the appearance of lesions in organs other than the skin. Acta Dermato-vener 58:189–190
Molin L, Thomsen K, Volden G (1979) Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction : report from the Scandinavian mycosis fungoides study group. Acta Dermatol 59:64–68
Molin L, Thomsen K, Volden G, Groth O (1980) Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian mycosis fungoides study group. Acta Dermatovenerol 61:47–51
Molin L, Thomsen K, Volden G, Groth O (1981) Photochemotherapy (PUVA) in the tumour stage of mycoses fungoides: a report from the Scandinavian fungoides study group. Acta Dermatovenerol 61:52–54
Moran EM, Walther JR, Arouson IK, Variakojis D (1977) Clinical significance of circulating Sézary cells in mycosis fungoides. Proc Am Soc Clin Oncol 18:276
Mortazawi SAM, Oberste-Lehn H (1973) Lichtsensibilisatoren und ihre therapeutischen Fähigkeiten. Erste vorläufige Mitteilung. Z Hautkr 48:1–9
Munson D, Bunn PA, Schechter GP (1982) Fc-Receptor-defined T-lymphocyte subpopulations in patients with cutaneous T-cell lymphoma. J Invest Dermatol 79:317–321
Neilau BA, Vonderheid EC, O’Neill KJ (1983) Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas. J Invest Dermatol 81:176–178
Nordqvist CB, Kinney PJ (1976) T and B cells and cell mediated immunity in mycosis fungoides. Cancer 37:714–721
Nowell PC, Finan JB, Vonderheid EC (1982) Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin. J Invest Derm 78:69–75
Oberste-Lehn H (1980) Photochemotherapie der T-Zellen-Lymphome. Z Hautkr 55:1335–1339
Olsen EA, Delzell E, Jegasothy BV (1984) Second malignancies in cutaneous T cell lymphoma. J Am Acad Dermatol 10:197–204
Oseroff AR, Miller RA, Stratte PJ, Levy R (1982) Monoclonal anti-T cell antibody in the therapy of mycosis fungoides. J Invest Dermatol 78:337
Patterson JAK, Edelson RL (1983) Interaction of T-lymphocytes with the epidermis: immunopatho-logical studies. J Cut Pathol 10:540–549
Pautrier LM, Woringer F (1932) Note préliminaire sur un tableau histologique particulier de lésions ganglionnaires accompagnant des éruptions dermatologiques généralisées prurigineuses, de types cliniques différents. Bull Soc Francaise Dermatol Syphilol 39:947–967
Payne CM, Nagle RB, Lynch PJ (1984) Quantitative electron microscopy in the diagnosis of mycosis fungoides. A simple analysis of lymphocytic nuclear convolutions. Arch Dermatol 120:63–75
Pierard GE, Franchimont C, de la Brassinne TLE, Lapiere CM (1982) Proliferation rate of cutaneous T cell lymphomas in the skin — relationship with histologic pattern and cytology. In : Lymphoproli-ferative diseases of the skin. Eds. Goos M, Christophers E, pp 65–70. Springer Verlag Berlin-Heidelberg-New York
Price NM, Mirkovich AM (1978) Lymphocytotoxicity in mycosis fungoides. Br J Derm 98:97–102
Price NM, Constantine VS, Hoppe RT, Fuks ZY, Färber EM (1977) Topical mechlorethamine therapy for mycosis fungoides. Br J Dermatol 97:547–555
Price NM, Fuks ZY, Hoffman TE (1977) Hyperkeratotic and verrucous features of mycosis fungoides. Arch Dermatol 113:57–60
Price NM, Deneau DG, Hoppe RT (1982) The treatment of mycosis fungoides with ointment-based mechlorethamine. Arch Dermatol 118:234–237
Price NM, Hoppe RT, Deneau DG (1983) Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer 52:2214–2219
Przybilla B, Burg G, Schmoeckel C, Braun-Falco O (1983) Treatment of cutaneous T-cell lymphomas with TP-5. Acta Dermatol Venerol 63:524–529
Rappaport H, Thomas LB (1974) Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 34:1198–1229
Reinherz EL, Kung PC, Goldstein RH, Levey RH, Schlossman SF (1980) Discrete stages of human intrathymus differentiation : analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 77:1588–1592
Resnick L, Schleider-Kushner N, Horwitz SN, Frost P (1984) Remission of tumor-stage mycosis fungoides following intravenously administered acyclovir. JAMA 251:1571–1573
Robb-Smith AHT (1944) The reticular tissue and the skin. Br J Dermatol 56:151–165
Roenigk HH (1977) Photochemotherapy of mycosis fungoides. Arch Dermatol 113:1047
Roenigk HH Jr, Castrovinci AJ (1971) Mycosis fungoides bullosa. Arch Dermatol 104:402–406
Rosas-Uribe A, Variakojis D, Molnar Z, Rappaport H (1974) Mycosis fungoides: an ultrastructural study. Cancer 34:634–645
Rowden G, Lewis MG (1976) Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol 95:665–672
Ruffieux C, Stalder M, Tran-Thang C (1984) Mycosis fungoides et gammopathie monoclonale. Association fortuite ou causale. Dermatologica 168:170–174
Rüssel Jones R, Chu AC (1981) Pagetoid reticulosis and solitary mycosis fungoides. Distinct clinico-pathological entities. J Cut Path 8:40–51
Samman PD (1972) The natural history of parapsoriasis en plaques (chronic superficial dermatitis) and prereticulotic poikiloderma. Br J Dermatol 87:405–411
Sanchez JL, Ackerman AB (1979) The patch stage of mycosis fungoides. Criteria for histologic diagnosis. Am J Dermatopathol 1:5–26
Sandbank M, Katzenellenbogen I (1968) Mycosis fungoides of prolonged duration in siblings. Arch Dermatol 98:620–627
Sauder DN, Carter C, Katz SI, Oppenheim JJ (1981) Epidermal cell production of thymocyte activating factor. Clin Research 29:285 A
Sauder DN, Noonan FP, DeFabo EC, Katz SI (1983) Ultraviolet radiation inhibits alloantigen presentation by epidermal cells : partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). J Invest Dermatol 80:485–489
Scheffer E, Meijer CJLM, van Vloten WA (1980) Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer 45:137–148
Schein PS, MacDonald JS, Edelson R (1976) Cutaneous T-cell lymphoma. Cancer 38:1859–1861
Schlaeger M (1980) Immunglobulin E bei kutanen Lymphomen und bei der Parapsoriasis en plaques (Brocq). Dermatologica 161:1–7
Schmitt D, Thivolet J (1980) Lymphocyte-epidermis interactions in malignant epidermotropic lymphoma: I. Ultrastructural aspects. Acta Dermatovener 60:1–11
Schmitt D, Alario A, Touraine JL, Claudy AL, Perrot H, Thivolet J (1977) Specific surface antigen of human B and T lymphocytes : the use in the ultrastructural identification of cells extracted from cutaneous infiltrations. J Cut Pathol 4:211–235
Schmitt D, Souteyrand P, Brochier J, Czernieliwski J, Thivolet J (1982) Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions) : Immunomorphological study with monoclonal antibodies. Acta Dermatovenerol 62:193–199
Schmoeckel C, Burg G, Braun-Falco O (1979) Quantitative analysis of lymphoid cells in mycosis fungoides, Sézary’s syndrome and parapsoriasis en plaques. Arch Dermatol Res 264:17–28
Schocket AL, Huff JC, Carr RI, Norris DA (1982) Humoral immunity in stage I mycosis fungoides: an increased incidence of lymphocytotoxic antibodies. Br J Dermatol 107:285–291
Schuppli R (1976) Is mycosis fungoides an “Immunoma”? Dermatologica 153:1–6
Segal RJ, Watson W (1978) Kaposi’s varicelliforme eruption in mycosis fungoides. Arch Dermatol 114:1067–1069
Shelley WB (1980) Familial mycosis fungoides revisited. Arch Dermatol 116:1177–1178
Sipos K (1965) Painting treatment of nitrogen mustard in mycosis fungoides. Dermatologica 130:3–11
Smith RW, Terry WD, Buell DN, Sell KW (1973) An antigenic marker for human thymic lymphocytes. J Immunol 110:884
Souteyrand P, Thivolet J, Fulton R (1981) Treatment of parapsoriasis en plaques and mycosis fungoides with an oral aromatic retinoid (Ro 10-9359). In: Retinoids. Advances in basic research and therapy. Edited by Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MR, Schuppli R, pp 313–316. Springer-Verlag, Berlin-Heidelberg-New York
Steigleder GK (1974) Die lymphoretikuläre Reaktion. Eine neue Theorie zur Entstehung der Lym-phoblastome (Immunoblastome). Z Hautkr 49:987–995
Steigleder GK (1976) Benign and malignant proliferative response. Acta Dermatovener 56:33–41
Steigleder GK (1978) Zur Pathogenese der kutanen malignen Lymphome und Pseudolymphome der Haut. Hautarzt Suppl III 29:31–33
Sterry W, Feller AC (1984) Immunohistochemical phenotyping of cutaneous T-cell lymphomas. Arch Dermatol Res 276:258
Sterry W, Pullmann H, Steigleder GK, Meisterernst E (1980a) Autoradiographic and enzyme cyto-chemical investigations in cutaneous lymphomas. Cell Tiss Kin 13:210
Sterry W, Steigleder GK, Nikolai B (1980b) Elevated colchicine sensitivity of dermal lymphocytes in mycosis fungoides. Acta Dermatovener 60:257–259
Sterry W, Steigleder GK, Pullmann H (1980c) In situ identification and enumeration of T lymphocytes in cutaneous T cell lymphomas by demonstration of granular activity of acid non-specific esterase. Br J Dermatol 103:67–72
Sterry W, Pullmann H, Steigleder GK (1981a) Proliferation kinetics of the dermal infiltrate in cutaneous malignant lymphomas. Arch Dermatol Res 270:285–290
Sterry W, Schulze HJ, Steigleder GK (1981b) Altered lymphocyte surface in mycosis fungoides. Arch Dermatol Res 270:249
Sterry W, Schulze HJ, Steigleder GK (1981c) Veränderte Zelloberfläche der dermalen Lymphozyten bei Mycosis fungoides. – Eine rasterelektronenmikroskopische Untersuchung. Z Hautkr 56:498–508
Sterry W, Steigleder GK, Goos M, Meisterernst E (1982) In situ identification and enumeration of helper T lymphocytes in cutaneous malignant lymphomas by dipeptidyl-peptidase IV (DPP IV). J Cut Pathol 9:119–120
Sterry W, Jansen M, Haneberg F, Steigleder GK (1983) Saure Esterase und Dipeptidyl-Peptidase IV als Marker immunologischer Lymphozytenpopulationen. Acta histochemica 28:181–190
Stingl G, Knapp W (1977) Characterization of neoplastic mononuclear cells on tissue sections. Hae-matol Blood Transfus 20:189–196
Stingl G, Gazze-Stingl LA, Aberer W, Wolff K (1981) Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J Immunol 127:1707–1713
Symmers D (1932) Mycosis fungoides as a clinical and pathological nonexistent. Arch Dermatol Syphil 25:1–5
Thomas JA, Janossy G, Graham-Brown RAC, Kung PC, Goldstein G (1982) The relationship between T-lymphocyte subsets and la-like antigen-positive nonlymphoid cells in early stages of cutaneous T-cell lymphoma. J Invest Dermatol 78:169–176
Tjernlund UM (1978) Epidermal expression of HLA-DR antigens in mycosis fungoides. Arch Derm Res 261:81–86
Touraine JL, Touraine F, Kiszkiss DF, Choi YS, Good RA (1974) Heterologous specific antiserum for identification of human T lymphocytes. Clin Exp Immunol 16:503–520
Tourbier H, Schultz-Ehrenburg U (1981) Etagenwechsel by Mycosis fungoides unter systemischer PUVA-Therapie. Z Hautkr 56:923–929
Tronnier H, Loehning R (1974) About the current status of the methoxalen UV-A therapy in dermatology. Castellania 2:267–271
United States Bureau of the Census (1963) In: US Census of population, 1960. Washington DC US Government Printing Office, Vol 1
van Leeuwen AWFM, Meijer CJLM, De Man JCH (1975) T-cell membrane characteristics of mycosis cells in the skin and lymph node. J Invest Dermatol 65:367–369
van Scott EJ, Kalmanson JD (1973) Complete remission of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2) : Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologie tolerance. Cancer 32:18–30
van Vloten WA, van Duijn P, Schaberg A (1974) Cytodiagnostic use of Feulgen-DNA measurements in cell imprints from the skin of patientes with mycosis fungoides. Br J Dermatol 91:365–371
van Vloten WA, Scheffer E, Meijer CJLM (1978) DNA cytophotometry of lymph nodes from patients with mycosis fungoides and Sézary’s syndrome. J Invest Dermatol 70:234
van Vloten WA, Scheffer E, Meijer CJLM (1979) DNA-cytophotometry of lymph node imprints from patients with mycosis fungoides. J Invest Dermatol 73:275–279
van Vloten WA, Pet EA, Geraedts JPM (1980) Chromosome studies in mycosis fungoides. Br J Dermatol 102:507–513
van der Harst-Oostveen CJGR, van Vloten WA (1978) Delayed-type hypersensitivity in patients with mycosis fungoides. Dermatologica 157:129–135
van der Loo EM, van Muijen GNP, van Vloten WA (1979) C-type virus-like particles specifically localized in Langerhans cells and related cells of skin and lymph nodes of patients with mycosis fungoides and Sézary syndrome. Virchows Arch B (Cell Pathol) 31:193–203
van der Loo EM, van Vloten WA, Cornelisse CJ, Scheffer E, Meijer CJLM (1981) The relevance of morphometry in the differential diagnosis of cutaneous T cell lymphomas. Br J Dermatol 104:257–269
van der Putte SCJ, van der Meer (1981) Mycosis fungoides : a morphological study. Clin exp Dermatol 6:57–76
Variakojis D, Rosas-Uribe A, Rappaport H (1974) Mycosis fungoides — pathologic findings in staging laparotomies. Cancer 33:1589–1600
Vidal E, Brocq L (1885) Étude sur le mycosis fungoide. Le France Medical 2:946, 957, 969, 983, 993, 1005, 1019, 1085
Viver A du, Vollum DI (1980) Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides. Br J Dermatol 102:319–322
Vivier A du, Vonderheid EC, van Scott EJ, Urbach F (1978) Mycosis fungoides, nitrogen mustard and skin cancer. Br J Dermatol 99:61–63
Volc-Platzer B, Majdic O, Wolff K, Knapp W, Stingl (1984) la antigens on keratinocytes in diseased skin. Arch Dermatol Res 276:258–259
Volden G (1980) A study of the photosensitive factor in relation to skin lesions of mycosis fungoides patients. Dermatologica 161:89–92
Volden G, Thune PO (1977) Light sensitivity in mycosis fungoides. Br J Dermatol 97:279–284
Vonderheid EC (1984) Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides. Int J Dermatol 23:180–186
Vonderheid EC, van Voorst Vader PC (1980) Herpes Zoster-Varicella in cutaneous T-cell lymphomas. Arch Dermatol 116:408–412
Vonderheid EC, van Scott EJ, Wallner PE, Johnson WC (1979) A ten year experience with topical mechlorethamine for mycosis fungoides : comparison with patients treated by total-skin electron-beam radiation therapy. Cancer Treat Rep 63:681–689
Vonderheid EC, Milstein HJ, Thompson KR, Wu BC (1980) Chronic herpes simplex infection in cutaneous T-cell lymphomas. Arch Dermatol 116:1018–1022
Wadell CC, Zubler MA, Gore WS (1982) Acute myeloblastic leukemia following chemotherapy for mycosis fungoides. Arch Dermatol 118:179–182
Warin AP (1981) Photochemotherapy in the treatment of psoriasis and mycosis fungoides. Clin Exp Dermatol 6:651–657
Weber G (1975) Blacklight-Meladinine : eine neue Dimension in der Dermatotherapie. Dtsch Ärzteblatt 72:1407–1410
Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD (1982) Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 50:1539–1553
White SI, Marsden JR, Marks JM, Proctor S (1984) Autoimmune haematolytic anaemia occuring in a patient with mycosis fungoides. Br J Dermatol 110:495–497
Wiklund D, Norris DA, Morris RJ, Sanderson RJ, Weston WL (1979) Monocyte function and subpopulation in mycosis fungoides. Clin Res 27:139A
Willemze R, de Graff-Reitsma CB, Cnossen J, van Vloten WA, Meijer CJLM (1983) Characterization of T-cell lymphomas and benign inflammatory dermatoses. J Invest Dermatol 80:60–66
Winkler CF, Bunn PA (1984) Combination chemotherapy in cutaneous lymphomas. In: Progress in diseases of the skin. Vol. 2. Ed. Fleischmajer R. Grune and Stratton. Orlando — San Diego – San Francisco – New York – London – Toronto – Montreal – Sydney – Tokyo – Sao Paulo, pp 185–215
Wiskemann A (1980) Röntgentherapie der Haut. In: Dermatologie in Praxis und Klinik. Hrsg.: Korting GW, Thieme Verlag, Stuttgart, Bd 1, pp 734–749
Wolf AF, Landes E (1984) Mycosis fungoides mit Beteiligung des Zentralnervensystems. Hautarzt 35:22–26
Worm AM, Hastrup N, Hou-Jensen K, Thomsen K (1978) Bone marrow involvement in mycosis fungoides demonstrated by needle biopsy. J Cutan Pathol 5:31–34
Yamamura T, Aozasa K, Sano S (1984) The cutaneous lymphomas with convoluted nuclei. J Am Acad Dermatol 10:796–803
Yambe H, Ishii Y, Kikuchi K, Jimbow K (1981) E-rosette inhibitory factor in sera from patients with mycosis fungoides. J Invest Dermatol 76:376–380
Yeckley JA, Weston WL, Thorne EG (1975) Production of Sézary-like cells from normal human lymphocytes. Arch Dermatol 111:29–32
Zachariae H, Grunnet E, Ellegaard J, Thestrup-Pedersen K (1975) Transfer factor as an additional therapeutic agent in mycosis fungoides. Acta Allergol 30:272
Zachariae H, Grunnet E, Thestrup-Pedersen K (1979) Transfer factor in mycosis fungoides: a case report on a patient “cured”. Acta Dermatovenerol 59:375–378
Zachariae H, Grunnet E, Thestrup-Pedersen K, Molin L, Schmidt H, Starfelt F, Thomsen K (1982) Oral retinoid in combination with bleomycin, cyclophosphamid, prednisone and transfer factor in mycosis fungoides. Acta Dermatovenerol 62:162–164
Zackheim HS, Epstein EH (1975) Treatment of mycosis fungoides with topical nitrosourea compounds. Arch Dermatol 111:1564–1570
Editor information
Editors and Affiliations
Additional information
Dedicated to Prof. Dr. med. G.K. Steigleder for his 60th anniversary.
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Sterry, W. (1985). Mycosis fungoides. In: Berry, C.L. (eds) Dermatopathology. Current Topics in Pathology, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69574-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-69574-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69576-6
Online ISBN: 978-3-642-69574-2
eBook Packages: Springer Book Archive